Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
STK25 inhibitor (Sprint Bioscience)
- Development stage
- Preclinical
- Lead developer
- Sprint Bioscience
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Sprint Bioscience is developing a small molecule inhibitor targeting serine/threonine kinase 25 (STK25) for the treatment of metabolic dysfunction-associated steatohepatitis (MASH). STK25 is a protein kinase that plays a key role in regulating lipid storage, inflammatory signaling, and fibrotic pathways within the liver. By inhibiting STK25 activity, the candidate aims to reduce hepatic fat accumulation and prevent the progression of liver fibrosis. The program was initially licensed to LG Chem in 2019 but returned to Sprint Bioscience in 2023. In 2025, Sprint entered a collaboration with the Experimental Drug Development Centre (EDDC) to further explore the molecule's potential in MASH and other inflammatory conditions.
- Other names
- STK25STK-25STK 25
02
Targets
STK25 (Serine/threonine kinase 25)
Beyond the preview
Go deeper on STK25 inhibitor (Sprint Bioscience).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on STK25 inhibitor (Sprint Bioscience).